Market Overview

NGM Biopharmaceuticals, Inc. (NGM)

18.95 -0.28 (-1.46%)

Analyst Ratings

DateResearch FirmActionCurrentPT
7/31/20Piper SandlerInitiates Coverage OnOverweight30.0
7/07/20Chardan CapitalInitiates Coverage OnBuy40.0
6/05/20BMO CapitalInitiates Coverage OnOutperform30.0
5/14/20Raymond JamesMaintainsStrong Buy32.0
4/07/20Raymond JamesInitiates Coverage OnStrong Buy31.0
3/27/20CitigroupMaintainsBuy28.0
3/19/20StifelMaintainsBuy32.0
2/26/20B. Riley FBRMaintainsBuy30.0
2/25/20Stifel NicolausMaintainsBuy33.0
10/17/19B. RileyInitiates Coverage OnBuy24.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter